XBiotech market cap is $510.9 m, and annual revenue was $44 m in FY 2020

XBiotech Gross profit (FY, 2020)9.4 M

XBiotech Gross profit margin (FY, 2020), %21.5%

XBiotech Net income (FY, 2020)-11.2 M

XBiotech EBIT (FY, 2020)-18.3 M

XBiotech Cash, 31-Dec-2020237.4 M

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Revenue | 44.0m | |||

## Cost of goods sold | 34.5m | |||

## Gross profit | 9.4m | |||

| 21% | |||

## R&D expense | 26.4m | 15.7m | 24.1m | 9.5m |

## General and administrative expense | 7.6m | 5.3m | 7.1m | 18.2m |

## Operating expense total | 34.1m | 21.0m | 31.2m | 27.7m |

## EBIT | (34.1m) | (21.0m) | (31.2m) | (18.3m) |

| (42%) | |||

## Interest income | 354.0k | 400.0k | 564.0k | |

## Investment income | 2.5m | |||

## Pre tax profit | 718.5m | (12.8m) | ||

## Income tax expense | 49.8m | (1.6m) | ||

## Net Income | (33.1m) | (21.1m) | 668.6m | (11.2m) |

## EPS | (0.9) | (0.6) | 17.2 |

USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 12.7m | 15.5m | 10.5m | ||||||

## Cost of goods sold | 9.7m | 13.2m | 9.4m | ||||||

## Gross profit | 3.0m | 2.3m | 1.1m | ||||||

| 24% | 15% | 11% | ||||||

## R&D expense | 3.0m | 3.9m | 3.9m | 4.5m | 4.7m | 4.5m | 1.2m | 2.6m | 2.3m |

## General and administrative expense | 1.2m | 1.7m | 1.2m | 1.3m | 1.3m | 1.6m | 4.0m | 6.2m | 3.4m |

## Operating expense total | 4.2m | 5.6m | 5.1m | 5.8m | 6.0m | 6.1m | 5.2m | 8.8m | 5.8m |

## EBIT | (4.1m) | (5.6m) | (5.1m) | (5.8m) | (6.0m) | (6.1m) | (2.2m) | (6.5m) | (4.7m) |

| (17%) | (42%) | (44%) | ||||||

## Interest income | 64.0k | 107.0k | 100.0k | 78.0k | 51.0k | 250.0k | 1.9m | 306.0k | 124.0k |

## Pre tax profit | (366.0k) | (7.2m) | (3.2m) | ||||||

## Income tax expense | (352.0k) | (332.0k) | (668.0k) | ||||||

## Net Income | (4.1m) | (5.9m) | (5.1m) | (5.9m) | (5.9m) | (6.1m) | (14.0k) | (6.8m) | (2.5m) |

## EPS | (0.1) | (0.2) | (0.1) | (0.2) | (0.2) | (0.1) | (0.2) | (0.1) |

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Cash | 31.8m | 15.8m | 714.6m | 237.4m |

## Accounts Receivable | 4.1m | |||

## Prepaid Expenses | 1.6m | 1.2m | 1.7m | 582.0k |

## Current Assets | 33.3m | 17.0m | 716.3m | 325.9m |

## PP&E | 29.6m | 27.3m | 25.2m | 27.3m |

## Total Assets | 63.0m | 44.5m | 816.9m | 353.7m |

## Accounts Payable | 1.7m | 1.7m | 2.1m | 2.5m |

## Current Liabilities | 2.8m | 2.9m | 60.2m | 4.0m |

## Total Liabilities | 2.8m | 2.9m | 61.2m | 5.1m |

## Common Stock | 277.5m | 279.4m | 324.8m | 249.8m |

## Preferred Stock | ||||

## Retained Earnings | (216.6m) | (237.7m) | 430.9m | 97.6m |

## Total Equity | 60.2m | 41.4m | 755.6m | 348.6m |

## Financial Leverage | 1 x | 1.1 x | 1.1 x | 1 x |

USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|

## Cash | 28.4m | 24.8m | 20.8m | 12.0m | 44.9m | 40.3m | 241.5m | 229.7m | 238.4m |

## Accounts Receivable | 9.7m | 20.7m | 6.1m | ||||||

## Prepaid Expenses | 1.3m | 917.0k | 457.0k | 963.0k | 678.0k | 573.0k | 1.2m | 802.0k | 439.0k |

## Current Assets | 29.7m | 25.8m | 21.3m | 13.0m | 45.6m | 40.9m | 257.9m | 258.4m | 251.7m |

## PP&E | 29.1m | 28.5m | 27.9m | 26.8m | 26.3m | 25.7m | 25.0m | 24.9m | 26.2m |

## Total Assets | 58.9m | 54.3m | 49.2m | 39.8m | 71.9m | 66.6m | 358.4m | 358.8m | 353.4m |

## Accounts Payable | 1.2m | 1.5m | 878.0k | 1.9m | 1.6m | 1.1m | 5.6m | 5.2m | 3.9m |

## Current Liabilities | 2.4m | 2.8m | 2.3m | 2.8m | 2.5m | 2.0m | 10.2m | 14.1m | 6.2m |

## Total Liabilities | 2.5m | 2.8m | 2.3m | 2.8m | 2.5m | 2.0m | 11.3m | 15.2m | 7.3m |

## Common Stock | 277.8m | 278.4m | 278.9m | 280.7m | 319.0m | 320.1m | 242.9m | 246.4m | 251.8m |

## Retained Earnings | (220.6m) | (226.5m) | (231.6m) | (243.6m) | (249.4m) | (255.6m) | 104.2m | 97.3m | 94.8m |

## Total Equity | 56.4m | 51.5m | 46.9m | 37.0m | 69.4m | 64.6m | 347.1m | 343.6m | 346.1m |

## Financial Leverage | 1 x | 1.1 x | 1 x | 1.1 x | 1 x | 1 x | 1 x | 1 x | 1 x |

USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
---|---|---|---|---|

## Net Income | (33.1m) | (21.1m) | 668.6m | (11.2m) |

## Depreciation and Amortization | 1.5m | 2.4m | 2.4m | 2.2m |

## Accounts Receivable | (4.1m) | |||

## Accounts Payable | (2.7m) | (78.0k) | 496.0k | (334.0k) |

## Cash From Operating Activities | (33.6m) | (16.5m) | (18.3m) | (65.1m) |

## Purchases of PP&E | (1.4m) | (122.0k) | (204.0k) | (3.7m) |

## Cash From Investing Activities | (1.4m) | (122.0k) | 674.8m | (3.7m) |

## Cash From Financing Activities | 33.3m | 201.0k | 42.1m | (409.7m) |

## Net Change in Cash | (2.6m) | (15.9m) | 698.8m | (477.2m) |

## Income Taxes Paid | 54.1m |

USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|

## Net Income | (4.1m) | (10.0m) | (15.0m) | (5.9m) | (11.7m) | (17.9m) | (14.0k) | (6.9m) | (9.4m) |

## Depreciation and Amortization | 588.0k | 1.2m | 1.8m | 602.0k | 1.2m | 1.8m | 558.0k | 1.1m | 1.7m |

## Accounts Receivable | (9.7m) | (20.7m) | (6.1m) | ||||||

## Accounts Payable | (596.0k) | (275.0k) | (853.0k) | 99.0k | (212.0k) | (592.0k) | 3.5m | 3.1m | 542.0k |

## Cash From Operating Activities | (3.5m) | (7.4m) | (11.4m) | (4.7m) | (9.5m) | (14.5m) | (60.7m) | (72.2m) | (64.8m) |

## Purchases of PP&E | (34.0k) | (82.0k) | (114.0k) | (6.0k) | (37.0k) | (198.0k) | (389.0k) | (815.0k) | (1.5m) |

## Cash From Investing Activities | (34.0k) | (82.0k) | (114.0k) | (6.0k) | (37.0k) | (198.0k) | (389.0k) | (815.0k) | (1.5m) |

## Cash From Financing Activities | 201.0k | 201.0k | 201.0k | 741.0k | 38.6m | 38.9m | (412.1m) | (411.8m) | (409.6m) |

## Net Change in Cash | (3.4m) | (6.9m) | (10.9m) | (3.8m) | 29.1m | 24.5m | (473.1m) | (484.9m) | (476.2m) |

USD | FY, 2017 |
---|---|

## Financial Leverage | 1 x |